Contract analysis

I. Executive Summary This memorandum analyzes the impact of the Tax Cuts and Jobs Act ("TCJA"), Pub. L. No. 115-97, 131 Stat. 2054 (2017), effective January 1, 2018, on the transfer pricing positions of Penterra Pharmaceuticals Corp. ("PPC" or the "Company") that are currently under examination by the Internal Revenue Service (IRS Exam Team ID: LB&I-NE-TP-2022-00641, covering tax years 2017 through 2020). The purpose

II. Scope and Purpose This memorandum is intended to serve the following purposes: First, it analyzes the TCJA's impact across three critical dimensions of PPC's transfer pricing positions: (1) the statutory rate change from 35% to 21% and its effect on the dollar-exposure calculations associated with the IRS's proposed IRC § 482 adjustments; (2) the interaction between proposed IRC § 482 adjustments and the GILTI re

III. Background: PPC's IP Structure and the IRS's Proposed Adjustments A. The Cost-Sharing Arrangement and Royalty Structure PBI was incorporated on March 15, 2012, under the laws of Ireland as a Designated Activity Company. On July 1, 2012, PPC and PBI entered into a qualified cost-sharing arrangement (the "CSA") within the meaning of Treas. Reg. § 1.482-7. The CSA governs the development and exploitation of PPC's p

IV. The TCJA Rate Change: Impact on Transfer Pricing Exposure A. Corporate Tax Rate Reduction The most immediately consequential change enacted by the TCJA for purposes of PPC's transfer pricing examination is the reduction of the federal corporate income tax rate from 35% to 21%. This rate change, codified in IRC § 11(b) as amended by TCJA § 13001, applies to taxable years beginning after December 31, 2017. For TY 2

V. GILTI Regime (IRC § 951A) — Interaction with Transfer Pricing Adjustments A. Overview of GILTI The GILTI regime, enacted by TCJA § 14201 and codified at IRC § 951A, represents one of the most significant structural changes to the U.S. international tax system effected by the TCJA. GILTI is effective for taxable years of foreign corporations beginning after December 31, 2017, and for taxable years of U.S. sharehold

VI. BEAT Regime (IRC § 59A) — Interaction with Transfer Pricing Adjustments A. Overview of BEAT The Base Erosion and Anti-Abuse Tax ("BEAT"), enacted by TCJA § 14401 and codified at IRC § 59A, imposes a minimum tax on certain U.S. corporations that make substantial deductible payments to related foreign persons. The BEAT is designed to address base erosion through outbound payments that reduce U.S. taxable income. Th

VII. FDII Regime (IRC § 250) — Potential Interaction A. Overview. IRC § 250, enacted by TCJA § 14202, provides a deduction for "foreign-derived intangible income" ("FDII") that results in an effective U.S. tax rate of 13.125% on qualifying FDII (for taxable years beginning before January 1, 2026; 16.406% thereafter, when the deduction decreases from 37.5% to 21.875%). FDII is designed to incentivize U.S. corporations

VIII. Transition-Year Issues: TY 2017 A. Pre-TCJA Rate and No GILTI/BEAT TY 2017 occupies a unique position in the examination because it is subject to the pre-TCJA international tax regime in its entirety. The key features of the pre-TCJA regime as they bear on PPC's transfer pricing exposure are: 35% Corporate Rate. The federal corporate income tax rate applicable to TY 2017 is 35%, the highest rate in the examinat

IX. Impact on Settlement and Defense Strategy A. Rate Differential in Settlement Calculations Any settlement analysis must separately model the tax-dollar impact of adjustments for TY 2017 at the 35% rate and for TY 2018–2020 at the 21% rate. The GILTI offsets identified in Section V.C above must also be incorporated into the settlement model, as they materially affect the net tax cost of adjustments for the post-TCJ

X. Recommendations Based on the foregoing analysis, we recommend the following actions:

1. TY 2017 Focus. Devote particular attention and defense resources to defending PPC's TY 2017 transfer pricing positions, given the 35% corporate tax rate applicable to that year and the absence of any GILTI offset to mitigate the tax cost of an adverse adjustment. The TY 2017 positions carry the highest per-dollar exposure of any examination year, and any concession on TY 2017 should be viewed as approximately twic

2. GILTI Conforming Adjustments. Ensure that any settlement or agreed adjustment for TY 2018–2020 explicitly provides for corresponding reductions to PPC's GILTI inclusions on Forms 8992 and related schedules. The conforming GILTI adjustment is not automatic and must be affirmatively claimed by PPC. The settlement agreement or closing agreement should include specific language providing for the recomputation of PPC's

3. FDII Analysis. Commission further analysis from Whitmore Valuation Group on whether any portion of income recharacterized under § 482 could qualify as foreign-derived intangible income under IRC § 250, thereby benefiting from the reduced 13.125% effective rate. This analysis should model the FDII benefit under various recharacterization scenarios and should address the related-party limitations of IRC § 250(b)(5)(

5. BEAT Monitoring. Continue to monitor PPC's base erosion percentage on an annual basis to confirm that PPC does not cross the 3% threshold that would make it an "applicable taxpayer" for BEAT purposes. This monitoring should be conducted in coordination with Crestfield & Associates (engagement partner: Martin Ogilvy, CPA) and should include a review of all intercompany payments from PPC to foreign affiliates, inclu

6. Settlement Modeling. Incorporate the rate differential, GILTI offsets, potential FDII benefits, § 965 interaction, and all other TCJA-related considerations into the sensitivity analysis and settlement range modeling being prepared for the defense. The settlement model should compute the aggregate tax cost of various adjustment scenarios, allocating adjustments across TY 2017–2020 in varying proportions, and shoul

XI. Conclusion The Tax Cuts and Jobs Act significantly reduces Penterra Pharmaceuticals Corp.'s per-dollar transfer pricing exposure for TY 2018–2020 compared to TY 2017, operating through two principal mechanisms. First, the rate reduction from 35% to 21% directly reduces the federal income tax attributable to each dollar of IRC § 482 adjustment by 40%. Second, the GILTI regime's interaction with § 482 adjustments c